Cargando…
Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance
Background: Diabetes and obesity are increasingly significant public health issues. The aim of this study was to evaluate the relationship between adipocytokines (leptin, ghrelin, and chemerin), inflammation (sVCAM1—soluble vascular adhesion molecule 1, sICAM1—soluble intercellular adhesion molecule...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564772/ https://www.ncbi.nlm.nih.gov/pubmed/32858998 http://dx.doi.org/10.3390/jcm9092767 |
_version_ | 1783595790271250432 |
---|---|
author | Sitar-Taut, Adela-Viviana Coste, Sorina Cezara Tarmure, Simina Orasan, Olga Hilda Fodor, Adriana Negrean, Vasile Pop, Dana Zdrenghea, Dumitru Login, Cezar Tiperciuc, Brandusa Cozma, Angela |
author_facet | Sitar-Taut, Adela-Viviana Coste, Sorina Cezara Tarmure, Simina Orasan, Olga Hilda Fodor, Adriana Negrean, Vasile Pop, Dana Zdrenghea, Dumitru Login, Cezar Tiperciuc, Brandusa Cozma, Angela |
author_sort | Sitar-Taut, Adela-Viviana |
collection | PubMed |
description | Background: Diabetes and obesity are increasingly significant public health issues. The aim of this study was to evaluate the relationship between adipocytokines (leptin, ghrelin, and chemerin), inflammation (sVCAM1—soluble vascular adhesion molecule 1, sICAM1—soluble intercellular adhesion molecule 1), and insulin resistance in the presence of obesity and diabetes mellitus. Methods: 88 subjects, with a mean age of 61.96 ± 10.15 years, 75% of whom were women, were evaluated (in order to consider different associations between obesity and diabetes, subjects were categorized into four groups). Results: Overall, we found significant correlations between sICAM1-sVCAM1 rho = 0.426 and ghrelin-chemerin rho = −0.224. In the obesity + diabetes group, leptin correlated with sICAM1 rho = 0.786, and sVCAM1 negatively with glycemia/insulin rho = −0.85. Significant differences were found between the groups regarding sVCAM1 (p = 0.0134), leptin (p = 0.0265) and all insulin resistance scores, with differences influenced by the subjects’ gender. In conclusion, although there are currently many unknown aspects of the release and the role of various adipokines, in particular chemerin, its implication in early glucose metabolism dysregulation disorders seems very likely. |
format | Online Article Text |
id | pubmed-7564772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75647722020-10-26 Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance Sitar-Taut, Adela-Viviana Coste, Sorina Cezara Tarmure, Simina Orasan, Olga Hilda Fodor, Adriana Negrean, Vasile Pop, Dana Zdrenghea, Dumitru Login, Cezar Tiperciuc, Brandusa Cozma, Angela J Clin Med Article Background: Diabetes and obesity are increasingly significant public health issues. The aim of this study was to evaluate the relationship between adipocytokines (leptin, ghrelin, and chemerin), inflammation (sVCAM1—soluble vascular adhesion molecule 1, sICAM1—soluble intercellular adhesion molecule 1), and insulin resistance in the presence of obesity and diabetes mellitus. Methods: 88 subjects, with a mean age of 61.96 ± 10.15 years, 75% of whom were women, were evaluated (in order to consider different associations between obesity and diabetes, subjects were categorized into four groups). Results: Overall, we found significant correlations between sICAM1-sVCAM1 rho = 0.426 and ghrelin-chemerin rho = −0.224. In the obesity + diabetes group, leptin correlated with sICAM1 rho = 0.786, and sVCAM1 negatively with glycemia/insulin rho = −0.85. Significant differences were found between the groups regarding sVCAM1 (p = 0.0134), leptin (p = 0.0265) and all insulin resistance scores, with differences influenced by the subjects’ gender. In conclusion, although there are currently many unknown aspects of the release and the role of various adipokines, in particular chemerin, its implication in early glucose metabolism dysregulation disorders seems very likely. MDPI 2020-08-26 /pmc/articles/PMC7564772/ /pubmed/32858998 http://dx.doi.org/10.3390/jcm9092767 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sitar-Taut, Adela-Viviana Coste, Sorina Cezara Tarmure, Simina Orasan, Olga Hilda Fodor, Adriana Negrean, Vasile Pop, Dana Zdrenghea, Dumitru Login, Cezar Tiperciuc, Brandusa Cozma, Angela Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance |
title | Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance |
title_full | Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance |
title_fullStr | Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance |
title_full_unstemmed | Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance |
title_short | Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance |
title_sort | diabetes and obesity—cumulative or complementary effects on adipokines, inflammation, and insulin resistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564772/ https://www.ncbi.nlm.nih.gov/pubmed/32858998 http://dx.doi.org/10.3390/jcm9092767 |
work_keys_str_mv | AT sitartautadelaviviana diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT costesorinacezara diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT tarmuresimina diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT orasanolgahilda diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT fodoradriana diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT negreanvasile diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT popdana diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT zdrengheadumitru diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT logincezar diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT tiperciucbrandusa diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance AT cozmaangela diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance |